The federal government has extended pandemic-era flexibilities for telehealth prescriptions of controlled substances, in today's bite-sized hospital and health industry news from the District of Columbia and Michigan:
Telehealth has experienced significant growth due to pandemic-related flexibilities around care delivery and payment — but those flexibilities are set to expire at the end of 2024. Delve into the challenges facing providers as they consider how (and if) they'll continue their telehealth programs.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
Never miss out on the latest innovative health care content tailored to you.